The NCI In Vitro Anticancer Drug Discovery Screen-Reference-Cited by-同舟云学术

The NCI In Vitro Anticancer Drug Discovery Screen

Published:1997 Issue: Volume: Page:23-42
ISSN:
Container-title:Anticancer Drug Development Guide
language:
Short-container-title:

Author:

Boyd Michael R.

Publisher

Humana Press

Link

http://link.springer.com/content/pdf/10.1007/978-1-4615-8152-9_2

Reference59 articles.

1. Driscoll JS. The preclinical new drug research program of the National Cancer Institute. Cancer Treatment Rep 1984; 68: 63–76.

2. Boyd JD, ed. National Cancer Institute planning to switch drug development emphasis from compound to human cancer-oriented strategy. Cancer Lett 1984; 10:1,2.

3. Boyd MR. National Cancer Institute drug discovery and development. In: Frei EII, Freireich E, eds. Accomplishments in Oncology. Philadelphia: Lippincott, 1986: 6876.

4. Boyd JD, ed. Division of Cancer Treatment Board approves new screening program, natural products concepts. Cancer Lett 1985; 11:4,5.

5. Boyd JD, ed. Reviewers report progress in new drug prescreen system development. Cancer Lett 1989; 15: 1–5.

Cited by 181 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and antitumor activity of 1,3,4-oxadiazole substituted 2-(5-ylidene-2,4-dioxothiazolidin-3-yl)-acetamides;Pharmacia;2023-10-12

2. Toxicological potential of Aloysia gratissima: Insights from chemical analysis and in vitro studies;Journal of Ethnopharmacology;2023-10

3. Cytotoxic Activities and Morphological Sudies of Thiophene, Thiazole and Pyridazine Derivatives Synthesized from Benzo[d]thiazole Derivatives;Acta Chimica Slovenica;2023-09-20

4. Analysis of Quinolinequinone Analogs with Promising Cytotoxic Activity against Breast Cancer;Chemistry & Biodiversity;2023-08-23

5. Ruthenium complexes for breast cancer therapy;Reviews in Inorganic Chemistry;2023-07-28